BRIEF published on 02/16/2026 at 15:35, 4 months 13 days ago Vanguard Group Discloses Position in Bluefield Solar Income Fund Form 8.3 Takeover Code Securities Disclosure Vanguard Group Bluefield Solar
BRIEF published on 02/16/2026 at 15:35, 4 months 13 days ago Le groupe Vanguard révèle sa participation dans le fonds Bluefield Solar Income. Groupe Vanguard Code De Prise De Contrôle Formulaire 8.3 Information Sur Les Valeurs Mobilières Bluefield Solar
BRIEF published on 02/16/2026 at 15:34, 4 months 13 days ago The Vanguard Group Postions on Beazley plc Shares Rule 8.3 Securities Disclosure Vanguard Group Share Transactions Beazley Plc
BRIEF published on 02/16/2026 at 15:34, 4 months 13 days ago Positions du groupe Vanguard sur les actions de Beazley plc Groupe Vanguard Règle 8.3 Transactions Sur Actions Informations Sur Les Valeurs Mobilières Beazley Plc
BRIEF published on 02/16/2026 at 15:33, 4 months 13 days ago Vanguard's Investment Position in Schroders plc Takeover Code Securities Disclosure Schroders Plc Vanguard Group Share Transactions
BRIEF published on 02/16/2026 at 15:33, 4 months 13 days ago Position d'investissement de Vanguard dans Schroders plc Schroders Plc Groupe Vanguard Code De Prise De Contrôle Transactions Sur Actions Information Sur Les Valeurs Mobilières
BRIEF published on 02/16/2026 at 15:32, 4 months 13 days ago The Vanguard Group Discloses Position in Spire Healthcare The Vanguard Group Takeover Code Securities Disclosure Spire Healthcare Share Transactions
BRIEF published on 02/16/2026 at 15:32, 4 months 13 days ago Le groupe Vanguard révèle sa participation dans Spire Healthcare Spire Healthcare Code De Prise De Contrôle Le Groupe Vanguard Transactions Sur Actions Information Sur Les Valeurs Mobilières
BRIEF published on 02/16/2026 at 15:32, 4 months 13 days ago The Vanguard Group Discloses Position in Oxford Biomedica Form 8.3 Takeover Code Securities Disclosure Vanguard Group Oxford Biomedica
BRIEF published on 02/16/2026 at 15:32, 4 months 13 days ago Le groupe Vanguard dévoile sa position dans Oxford Biomedica Groupe Vanguard Code De Prise De Contrôle Formulaire 8.3 Information Sur Les Valeurs Mobilières Oxford Biomedica
Published on 06/29/2026 at 15:00, 1 hour 50 minutes ago Infield Minerals Significantly Expands Land Holdings and Builds Regional Presence at the Detroit Gold Project in Utah
Published on 06/29/2026 at 15:00, 1 hour 50 minutes ago Vox Royalty Highlights Significant Gold Offtake-Stream Exposure to Los Filos Following Key Milestone Announcement
Published on 06/29/2026 at 14:30, 2 hours 20 minutes ago Unusual Machines Added to Russell 2000(R) Index
Published on 06/29/2026 at 14:30, 2 hours 20 minutes ago Sekur Private Data Makes First Intl. Call on SekurOne - Launches SekurOne for Android and Web
Published on 06/29/2026 at 14:30, 2 hours 20 minutes ago US FDA Has Granted A "Rare Pediatric Disease Drug" Designation for NV-387 As A Treatment for Measles - Enables Priority Review Voucher
Published on 06/29/2026 at 16:29, 20 minutes ago Aroundtown SA notification of a change in major holdings pursuant to the modified law and grand-ducal regulation of 11 January 2008 on transparency requirements for issuers of securities
Published on 06/29/2026 at 16:29, 20 minutes ago Aroundtown SA notification of a change in major holdings pursuant to the modified law and grand-ducal regulation of 11 January 2008 on transparency requirements for issuers of securities
Published on 06/29/2026 at 15:34, 1 hour 15 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 06/29/2026 at 16:39, 10 minutes ago Statement of transactions in own shares from June 22, 2026 to June 26, 2026
Published on 06/29/2026 at 16:39, 10 minutes ago Déclaration des transactions sur actions propres réalisées du 22/06/2026 au 26/06/2026
Published on 06/29/2026 at 16:30, 20 minutes ago Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 06/29/2026 at 16:30, 20 minutes ago Capital increase through exercise of subscription rights
Published on 06/29/2026 at 10:56, 5 hours 53 minutes ago GUILLEMOT CORPORATION S.A. | Déclaration hebdomadaire des transactions sur actions propres du 22 au 26 juin 2026
